Vaccine Ontology
8696 terms(s) returned
| Term Type: | Record: 6951 to 7000 of 8696 Records | Page: 140 of 174, First Previous Next Last | Show Records Per Page |
- host response to vaccine component
- host response to vaccine vaccine vector
- host role
- host survival to pathogen challenge after vaccination
- host susceptibility gene response to vaccine adverse event
- htrA from Salmonella Typhimurium
- htrA from Yersinia enterocolitica
- human ACPP
- human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
- human Rabies vaccine
- human adenovirus vaccine vector
- human adolescence age range at vaccination
- human adult age range at vaccination
- human age
- human age 1 to 2 months at vaccination
- human age 11 to 12 years at vaccination
- human age 12 to 23 months at vaccination
- human age 19 to 26 years at vaccination
- human age 2 to 3 years at vaccination
- human age 27 to 59 years at vaccination
- human age 4 months at vaccination
- human age 4 to 6 years at vaccination
- human age 6 months at vaccination
- human age 7 to 10 years at vaccination
- human age 7 to 11 months at vaccination
- human age range at vaccination
- human age within one month at vaccination
- human albumin cell culture residual in vaccine
- human apo B-100 peptide-2 protein vaccine
- human child age range at vaccination
- human gene
- human ifng
- human immunization objective
- human immunodeficiency virus infectious disease
- human immunodeficiency virus vaccine
- human leukocyte antigen class I-modified peptide vaccine
- human papillomavirus vaccine
- human parasite role
- human protein
- human senior age range at vaccination
- human serum albumin
- human serum albumin vaccine additive
- human serum cell culture residual in vaccine
- human vaccinee
- human vaccinee at age 2-17 years old
- human vaccinee population
- human vaccinee population at age 2-17 years old
- hypersensitity to arginine
- hypersensitity to gelatin
- hypersensitivity to antibiotic
